Jump to top menu Jump to main menu Jump to content
News

VEO report on mutations and variation in publicly shared SARS-CoV-2 raw sequencing data

November 25, 2021

VEO submits the ninth report on mutations and variation in publicly shared SARS-CoV-2 raw sequencing data.

VEO logo

 

In its ninth report to the European Commission, VEO Consortium members summarize mobilisation and analysis of SARS-CoV-2 sequence data submitted to the European COVID-19 Data Platform in the context of the VEO project, which aims to develop tools and data analytics for pandemic and outbreak preparedness.

Summary:

  • Update on mobilisation of raw reads, now totaling sequencing data sets from 1,876,126 viral raw read sets from 80 countries, a 21% increase since the previous report.
  • The variant nomenclature has been updated, and tables on countries depositing data on VOC and VOI have been included.
  • The variant calling workflow for the Oxford Nanopore data has been implemented and 83,041 samples of the total 172,654 have been processed so far.
  • While data mobilisation is progressing, the contribution of countries in Europe is very low. Pathogen sequencing in most countries has been taken up as part of a public health effort, in part supported by HERA/ECDC. Agreements are needed to ensure release of raw data towards global sharing effort.

    Read the full report